Suppr超能文献

近期医院内传播的耐多药结核分枝杆菌及其基因型。

Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis.

机构信息

Clinic of Tuberculosis and Lung Diseases, Infectology Centre of Latvia, Riga, Latvia; Riga Stradins University, Riga, Latvia.

出版信息

Int J Tuberc Lung Dis. 2010 Apr;14(4):427-33.

Abstract

SETTING

Multidrug-resistant tuberculosis (MDR-TB) is a serious health problem in Eastern European countries, including Latvia.

OBJECTIVE

To investigate the proportion of tuberculosis, including MDR-TB cases, attributable to recent transmission and risk factors associated with clustering.

DESIGN

Retrospective nested case-control study. The data set incorporated a wide spectrum of social features, as well as genotypes of Mycobacterium tuberculosis isolates determined by insertion sequence 6110 restriction fragment length polymorphism analysis of PvuII cleaved genomic DNA and spoligotyping.

RESULTS

In comparison with non-clustered M. tuberculosis, the Beijing genotype (OR 12.15) and multidrug resistance (OR 5.61, P < 0.01) were associated with clustering. In comparison with clustered drug-susceptible M. tuberculosis, clustering of MDR M. tuberculosis was associated with Beijing genotype (OR 41.67), previous hospitalisation (OR 18.33) and previous TB treatment (OR 17.68, P < 0.05). Direct epidemiological links in hospitals were found for almost one third (32%) of MDR Beijing cases.

CONCLUSIONS

MDR cases were more likely to be found in clusters than drug-susceptible cases (74.0% vs. 33.6%). Recent nosocomial transmission of MDR-TB is an important risk factor for the spread of multiresistance, and is associated with the Beijing genotype. Special attention should be paid to infection control measures in hospitals and ambulatory treatment should be enforced.

摘要

背景

耐多药结核病(MDR-TB)是东欧国家,包括拉脱维亚的一个严重的健康问题。

目的

调查包括耐多药结核病(MDR-TB)病例在内的结核病病例归因于近期传播的比例和与聚集相关的危险因素。

设计

回顾性巢式病例对照研究。该数据集包含了广泛的社会特征,以及通过插入序列 6110 限制片段长度多态性分析 PvuII 切割基因组 DNA 和 spoligotyping 确定的结核分枝杆菌分离株的基因型。

结果

与非聚集性结核分枝杆菌相比,北京基因型(OR 12.15)和耐多药(OR 5.61,P < 0.01)与聚集有关。与聚集性耐药结核分枝杆菌相比,北京基因型(OR 41.67)、既往住院(OR 18.33)和既往结核病治疗(OR 17.68,P < 0.05)与 MDR 结核分枝杆菌的聚集有关。几乎三分之一(32%)的 MDR 北京病例在医院发现了直接的流行病学联系。

结论

MDR 病例比耐药性病例更有可能聚集(74.0%比 33.6%)。MDR-TB 的近期医院内传播是耐药传播的一个重要危险因素,与北京基因型有关。应特别注意医院的感染控制措施,并加强门诊治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验